ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus
Patients with systemic lupus erythematosus (SLE) appear to have an increased risk of developing malignancies, especially lymphomas. We report the development of a systemic ALK-negative T-cell anaplastic large cell lymphoma, stage IIB, in a 53-yr-old Caucasian female with a 12-yr history of stable SL...
Gespeichert in:
| Veröffentlicht in: | Medical oncology (Northwood, London, England) London, England), 2003-01, Vol.20 (4), p.409-412 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 412 |
|---|---|
| container_issue | 4 |
| container_start_page | 409 |
| container_title | Medical oncology (Northwood, London, England) |
| container_volume | 20 |
| creator | Suvajdzic, Nada Stojanovic-Milenkovic, Roksanda Tomasevic, Zoran Cemerikic-Martinovic, Vesna Mihaljevic, Biljana Atkinson, Henry D E |
| description | Patients with systemic lupus erythematosus (SLE) appear to have an increased risk of developing malignancies, especially lymphomas. We report the development of a systemic ALK-negative T-cell anaplastic large cell lymphoma, stage IIB, in a 53-yr-old Caucasian female with a 12-yr history of stable SLE. The patient responded poorly to chemotherapy and died 2 yr after diagnosis. Lymphomas that develop in patients with SLE and other autoimmune diseases are virtually always of B-cell origin. To our knowledge this is the first report of a T-cell anaplastic large cell lymphoma in a patient with SLE. This article discusses the association of SLE and lymphoma, with an emphasis on T-lymphoproliferative states. |
| doi_str_mv | 10.1385/MO:20:4:409 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71514853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2394108361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-ebb9189eb349f334ccde7ac96ce431d22eab7071d430061edda3d2c3b3f3546b3</originalsourceid><addsrcrecordid>eNpd0MtLw0AQBvBFFKvVk3cJHrxIdJ_ZpLdSfGFLL_W8bHYnbUpeZjdK_ntTW1A8zTD8-Bg-hK4IvicsFg-L5YTiCZ9wnByhM8KEDLGI8PGffYTOndtiTImgySkaES5JhDk-Q2o6fwsrWGuff0KwCg0URaAr3RTa-dwEhW7XEPxci75sNnWpA-1cbXLtwQZfud8Ernceyh3ums4F0PZ-A6X2tevcBTrJdOHg8jDH6P3pcTV7CefL59fZdB4aRqgPIU0TEieQMp5kjHFjLEhtksgAZ8RSCjqVWBLLGcYRAWs1s9SwlGVM8ChlY3S7z23a-qMD51WZu93buoK6c0oSQXgs2ABv_sFt3bXV8JuKpRCSUBYP6G6PTFs710KmmjYvddsrgtWudLVYKooVV0Ppg74-RHZpCfbXHlpm3wGQfaM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>875571238</pqid></control><display><type>article</type><title>ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Suvajdzic, Nada ; Stojanovic-Milenkovic, Roksanda ; Tomasevic, Zoran ; Cemerikic-Martinovic, Vesna ; Mihaljevic, Biljana ; Atkinson, Henry D E</creator><creatorcontrib>Suvajdzic, Nada ; Stojanovic-Milenkovic, Roksanda ; Tomasevic, Zoran ; Cemerikic-Martinovic, Vesna ; Mihaljevic, Biljana ; Atkinson, Henry D E</creatorcontrib><description>Patients with systemic lupus erythematosus (SLE) appear to have an increased risk of developing malignancies, especially lymphomas. We report the development of a systemic ALK-negative T-cell anaplastic large cell lymphoma, stage IIB, in a 53-yr-old Caucasian female with a 12-yr history of stable SLE. The patient responded poorly to chemotherapy and died 2 yr after diagnosis. Lymphomas that develop in patients with SLE and other autoimmune diseases are virtually always of B-cell origin. To our knowledge this is the first report of a T-cell anaplastic large cell lymphoma in a patient with SLE. This article discusses the association of SLE and lymphoma, with an emphasis on T-lymphoproliferative states.</description><identifier>ISSN: 1357-0560</identifier><identifier>EISSN: 1357-0560</identifier><identifier>EISSN: 1559-131X</identifier><identifier>DOI: 10.1385/MO:20:4:409</identifier><identifier>PMID: 14716040</identifier><identifier>CODEN: MONCEZ</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Adult ; Carcinoma - drug therapy ; Carcinoma - etiology ; Carcinoma - pathology ; Fatal Outcome ; Female ; Humans ; Lupus Erythematosus, Systemic - complications ; Lymphoma, T-Cell - drug therapy ; Lymphoma, T-Cell - etiology ; Lymphoma, T-Cell - pathology ; Oncology</subject><ispartof>Medical oncology (Northwood, London, England), 2003-01, Vol.20 (4), p.409-412</ispartof><rights>Humana Press Inc. 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-ebb9189eb349f334ccde7ac96ce431d22eab7071d430061edda3d2c3b3f3546b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14716040$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suvajdzic, Nada</creatorcontrib><creatorcontrib>Stojanovic-Milenkovic, Roksanda</creatorcontrib><creatorcontrib>Tomasevic, Zoran</creatorcontrib><creatorcontrib>Cemerikic-Martinovic, Vesna</creatorcontrib><creatorcontrib>Mihaljevic, Biljana</creatorcontrib><creatorcontrib>Atkinson, Henry D E</creatorcontrib><title>ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus</title><title>Medical oncology (Northwood, London, England)</title><addtitle>Med Oncol</addtitle><description>Patients with systemic lupus erythematosus (SLE) appear to have an increased risk of developing malignancies, especially lymphomas. We report the development of a systemic ALK-negative T-cell anaplastic large cell lymphoma, stage IIB, in a 53-yr-old Caucasian female with a 12-yr history of stable SLE. The patient responded poorly to chemotherapy and died 2 yr after diagnosis. Lymphomas that develop in patients with SLE and other autoimmune diseases are virtually always of B-cell origin. To our knowledge this is the first report of a T-cell anaplastic large cell lymphoma in a patient with SLE. This article discusses the association of SLE and lymphoma, with an emphasis on T-lymphoproliferative states.</description><subject>Adult</subject><subject>Carcinoma - drug therapy</subject><subject>Carcinoma - etiology</subject><subject>Carcinoma - pathology</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>Humans</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Lymphoma, T-Cell - drug therapy</subject><subject>Lymphoma, T-Cell - etiology</subject><subject>Lymphoma, T-Cell - pathology</subject><subject>Oncology</subject><issn>1357-0560</issn><issn>1357-0560</issn><issn>1559-131X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0MtLw0AQBvBFFKvVk3cJHrxIdJ_ZpLdSfGFLL_W8bHYnbUpeZjdK_ntTW1A8zTD8-Bg-hK4IvicsFg-L5YTiCZ9wnByhM8KEDLGI8PGffYTOndtiTImgySkaES5JhDk-Q2o6fwsrWGuff0KwCg0URaAr3RTa-dwEhW7XEPxci75sNnWpA-1cbXLtwQZfud8Ernceyh3ums4F0PZ-A6X2tevcBTrJdOHg8jDH6P3pcTV7CefL59fZdB4aRqgPIU0TEieQMp5kjHFjLEhtksgAZ8RSCjqVWBLLGcYRAWs1s9SwlGVM8ChlY3S7z23a-qMD51WZu93buoK6c0oSQXgs2ABv_sFt3bXV8JuKpRCSUBYP6G6PTFs710KmmjYvddsrgtWudLVYKooVV0Ppg74-RHZpCfbXHlpm3wGQfaM</recordid><startdate>20030101</startdate><enddate>20030101</enddate><creator>Suvajdzic, Nada</creator><creator>Stojanovic-Milenkovic, Roksanda</creator><creator>Tomasevic, Zoran</creator><creator>Cemerikic-Martinovic, Vesna</creator><creator>Mihaljevic, Biljana</creator><creator>Atkinson, Henry D E</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20030101</creationdate><title>ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus</title><author>Suvajdzic, Nada ; Stojanovic-Milenkovic, Roksanda ; Tomasevic, Zoran ; Cemerikic-Martinovic, Vesna ; Mihaljevic, Biljana ; Atkinson, Henry D E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-ebb9189eb349f334ccde7ac96ce431d22eab7071d430061edda3d2c3b3f3546b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Carcinoma - drug therapy</topic><topic>Carcinoma - etiology</topic><topic>Carcinoma - pathology</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>Humans</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Lymphoma, T-Cell - drug therapy</topic><topic>Lymphoma, T-Cell - etiology</topic><topic>Lymphoma, T-Cell - pathology</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suvajdzic, Nada</creatorcontrib><creatorcontrib>Stojanovic-Milenkovic, Roksanda</creatorcontrib><creatorcontrib>Tomasevic, Zoran</creatorcontrib><creatorcontrib>Cemerikic-Martinovic, Vesna</creatorcontrib><creatorcontrib>Mihaljevic, Biljana</creatorcontrib><creatorcontrib>Atkinson, Henry D E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Medical oncology (Northwood, London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suvajdzic, Nada</au><au>Stojanovic-Milenkovic, Roksanda</au><au>Tomasevic, Zoran</au><au>Cemerikic-Martinovic, Vesna</au><au>Mihaljevic, Biljana</au><au>Atkinson, Henry D E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus</atitle><jtitle>Medical oncology (Northwood, London, England)</jtitle><addtitle>Med Oncol</addtitle><date>2003-01-01</date><risdate>2003</risdate><volume>20</volume><issue>4</issue><spage>409</spage><epage>412</epage><pages>409-412</pages><issn>1357-0560</issn><eissn>1357-0560</eissn><eissn>1559-131X</eissn><coden>MONCEZ</coden><abstract>Patients with systemic lupus erythematosus (SLE) appear to have an increased risk of developing malignancies, especially lymphomas. We report the development of a systemic ALK-negative T-cell anaplastic large cell lymphoma, stage IIB, in a 53-yr-old Caucasian female with a 12-yr history of stable SLE. The patient responded poorly to chemotherapy and died 2 yr after diagnosis. Lymphomas that develop in patients with SLE and other autoimmune diseases are virtually always of B-cell origin. To our knowledge this is the first report of a T-cell anaplastic large cell lymphoma in a patient with SLE. This article discusses the association of SLE and lymphoma, with an emphasis on T-lymphoproliferative states.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>14716040</pmid><doi>10.1385/MO:20:4:409</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1357-0560 |
| ispartof | Medical oncology (Northwood, London, England), 2003-01, Vol.20 (4), p.409-412 |
| issn | 1357-0560 1357-0560 1559-131X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71514853 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Adult Carcinoma - drug therapy Carcinoma - etiology Carcinoma - pathology Fatal Outcome Female Humans Lupus Erythematosus, Systemic - complications Lymphoma, T-Cell - drug therapy Lymphoma, T-Cell - etiology Lymphoma, T-Cell - pathology Oncology |
| title | ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T01%3A04%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ALK-negative%20T-cell%20anaplastic%20large%20cell%20lymphoma%20associated%20with%20systemic%20lupus%20erythematosus&rft.jtitle=Medical%20oncology%20(Northwood,%20London,%20England)&rft.au=Suvajdzic,%20Nada&rft.date=2003-01-01&rft.volume=20&rft.issue=4&rft.spage=409&rft.epage=412&rft.pages=409-412&rft.issn=1357-0560&rft.eissn=1357-0560&rft.coden=MONCEZ&rft_id=info:doi/10.1385/MO:20:4:409&rft_dat=%3Cproquest_cross%3E2394108361%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=875571238&rft_id=info:pmid/14716040&rfr_iscdi=true |